These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 5081012)
1. Notes on the development of plasma derivatives in the Netherlands. Krijnen HW Vox Sang; 1972; 23(1):32. PubMed ID: 5081012 [No Abstract] [Full Text] [Related]
2. The development of plasma derivatives in Canada. McVicar GA Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046 [No Abstract] [Full Text] [Related]
3. The development of plasma derivatives in Switzerland. Kistler P Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011 [No Abstract] [Full Text] [Related]
4. Experiences in the development of plasma derivatives in Japan. Naito R Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047 [No Abstract] [Full Text] [Related]
5. Notes on plasma derivative production in the Federal Republic of Germany. Schwick HG Vox Sang; 1972; 23(1):44. PubMed ID: 5081013 [No Abstract] [Full Text] [Related]
6. The development of plasma derivatives in Australia. Schiff P Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156 [No Abstract] [Full Text] [Related]
7. Development of plasma derivatives for clinical use. Tullis JL Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048 [No Abstract] [Full Text] [Related]
8. Fractionation of plasma with polyethylene glycol. Polson A; Ruiz-Bravo C Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005 [No Abstract] [Full Text] [Related]
9. Notes on the production of plasma derivatives in France. Steinbuch M Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049 [No Abstract] [Full Text] [Related]
10. Plasma fractionation in England and Wales. Vallet L Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157 [No Abstract] [Full Text] [Related]
11. Precipitation methods in plasma fractionation. Steinbuch M Vox Sang; 1972; 23(1):92-106. PubMed ID: 5081018 [No Abstract] [Full Text] [Related]
12. Round table discussion on regulatory and other problems, including hepatitis, in the development of plasma derivatives. Vox Sang; 1972; 23(1):72-9. PubMed ID: 5081017 [No Abstract] [Full Text] [Related]
14. The current status of blood fractionation in the United States. Sgouris JT Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014 [No Abstract] [Full Text] [Related]
15. The development of plasma derivatives for clinical use. A symposium summary. Deutsch HF Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010 [No Abstract] [Full Text] [Related]
16. [Lymphocyte subpopulations and the presence of abnormal proteins in plasma concentrates]. Vicente V; Alberca I; González R; López Borrasca A Med Clin (Barc); 1985 Apr; 84(16):675-6. PubMed ID: 4033246 [No Abstract] [Full Text] [Related]
17. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617 [TBL] [Abstract][Full Text] [Related]
19. New plasma components. Sherman LA Clin Haematol; 1984 Feb; 13(1):17-38. PubMed ID: 6373081 [No Abstract] [Full Text] [Related]
20. The activity of the Netherlands Red Cross in the field of blood transfusion service. SPAANDER J Maandschr Kindergeneeskd; 1950; 18(3/4):86-102. PubMed ID: 15438065 [No Abstract] [Full Text] [Related] [Next] [New Search]